Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus vs Cyclosporine in Primary Renal Allograft Recipients
NCT00137345Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jun 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of sirolimus in kidney transplant rejection, sponsored by Pfizer. Started Jun 2005; status: terminated.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00137345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00137345.